Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polymyxin B plus meropenem in carbapenem-resistant Klebsiella pneumoniae bloodstream infection
ChiCTR1900021137Phase 4Not yet recruiting
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Feb 2019
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of polymyxin B and meropenem (2 arms), sponsored by Sir Run-Run Shaw Hospital. Primary endpoints: Pharmacokinetics, 28-day all-cause mortality and 1 more. Planned start Feb 2019; status: not yet recruiting.
02
Drugs
polymyxin Bmeropenem
Beyond the preview
Go deeper on ChiCTR1900021137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021137.